Zimmer Biomet Holdings, Inc. (ZBH)
100.91
+1.43
(+1.44%)
USD |
NYSE |
Aug 28, 16:00
100.92
0.00 (0.00%)
Pre-Market: 20:00
Zimmer Biomet Holdings Free Cash Flow : 1.079B for June 30, 2026
Free Cash Flow Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Free Cash Flow Data
| Date | Value |
|---|---|
| June 30, 2026 | 1.079B |
| March 31, 2026 | 1.050B |
| December 31, 2025 | 1.120B |
| September 30, 2025 | 1.131B |
| June 30, 2025 | 1.054B |
| March 31, 2025 | 1.10B |
| December 31, 2024 | 902.30M |
| September 30, 2024 | 979.50M |
| June 30, 2024 | 964.80M |
| March 31, 2024 | 806.90M |
| December 31, 2023 | 892.40M |
| September 30, 2023 | 559.20M |
| June 30, 2023 | 711.80M |
| March 31, 2023 | 793.60M |
| December 31, 2022 | 773.10M |
| September 30, 2022 | 897.00M |
| June 30, 2022 | 882.30M |
| March 31, 2022 | 1.062B |
| December 31, 2021 | 1.054B |
| September 30, 2021 | 1.151B |
| June 30, 2021 | 1.111B |
| March 31, 2021 | 594.60M |
| December 31, 2020 | 772.70M |
| September 30, 2020 | 750.30M |
| June 30, 2020 | 874.70M |
| Date | Value |
|---|---|
| March 31, 2020 | 991.30M |
| December 31, 2019 | 845.50M |
| September 30, 2019 | 761.60M |
| June 30, 2019 | 708.50M |
| March 31, 2019 | 1.041B |
| December 31, 2018 | 1.277B |
| September 30, 2018 | 1.311B |
| June 30, 2018 | 1.31B |
| March 31, 2018 | 1.333B |
| December 31, 2017 | 1.076B |
| September 30, 2017 | 1.289B |
| June 30, 2017 | 1.174B |
| March 31, 2017 | 1.085B |
| December 31, 2016 | 1.099B |
| September 30, 2016 | 912.20M |
| June 30, 2016 | 687.90M |
| March 31, 2016 | 562.40M |
| December 31, 2015 | 394.00M |
| September 30, 2015 | 380.60M |
| June 30, 2015 | 540.40M |
| March 31, 2015 | 590.10M |
| December 31, 2014 | 706.40M |
| September 30, 2014 | 748.20M |
| June 30, 2014 | 783.60M |
| March 31, 2014 | 668.40M |
Free Cash Flow Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Free Cash Flow Benchmarks
| Intuitive Surgical, Inc. | 3.223B |
| Stryker Corp. | 4.702B |
| Globus Medical, Inc. | 750.84M |
| Solventum Corp. | -118.00M |
| Boston Scientific Corp. | 3.625B |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | 447.80M |
| Cash from Investing (Quarterly) | -190.80M |
| Cash from Financing (Quarterly) | -271.10M |
| Free Cash Flow Per Share (Quarterly) | 1.276 |
| Free Cash Flow to Equity (Quarterly) | 238.00M |
| Free Cash Flow to Firm (Quarterly) | 303.35M |
| Free Cash Flow Yield | 5.44% |